{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:39:13Z","timestamp":1790163553356,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":656,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum-free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA-CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA-treated cultures were able to engraft in immune-deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA-mediated ex vivo HSC expansion for gene modification of adult HSCs.<\/jats:p>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Significance statement This study shows that the transplantation of ex vivo valproic acid (VPA)-treated, adult mobilized peripheral blood and bone marrow hematopoietic stem cells (HSCs) into immune-deficient mice led to nonbiased long-term multilineage hematopoietic cell engraftment including T cells. These data support the use of VPA-mediated ex vivo HSC expansion for future gene modification strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/sctm.19-0199","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T03:29:58Z","timestamp":1579231798000},"page":"531-542","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor"],"prefix":"10.1093","volume":"9","author":[{"given":"Eran","family":"Zimran","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"Hematology Department Hadassah University Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luena","family":"Papa","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Djedaini","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia","family":"Iancu-Rubin","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"issue":"2","key":"2022022809302389200_sct312661-bib-0001","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.stem.2012.01.006","article-title":"Hematopoiesis: a human perspective","volume":"10","author":"Dolatov","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"10","key":"2022022809302389200_sct312661-bib-0002","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1182\/blood.V96.10.3414","article-title":"An in vivo competitive repopulation assay for various sources of human hematopoitic stem cells","volume":"96","author":"Rosler","year":"2000","journal-title":"Blood"},{"key":"2022022809302389200_sct312661-bib-0003","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0301-472X(02)00818-4","article-title":"Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood","volume":"30","author":"Tanavde","year":"2002","journal-title":"Exp Hematol"},{"issue":"11","key":"2022022809302389200_sct312661-bib-0004","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1182\/blood.V89.11.3919","article-title":"Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating assay","volume":"89","author":"Wang","year":"1997","journal-title":"Blood"},{"issue":"3","key":"2022022809302389200_sct312661-bib-0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/17474086.2016.1128321","article-title":"Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications","volume":"9","author":"Baron","year":"2016","journal-title":"Exp Rev Hematol"},{"key":"2022022809302389200_sct312661-bib-0006","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.exphem.2016.04.007","article-title":"Optimizing autologous cell grafts to improve stem cell gene therapy","volume":"44","author":"Psatha","year":"2016","journal-title":"Exp Hematol"},{"key":"2022022809302389200_sct312661-bib-0007","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/hum.2016.107","article-title":"Gene editing of human hematopoietic stem and progenitor cells: promise and potential hurdles","volume":"107","author":"Yu","year":"2016","journal-title":"Human Gene Ther"},{"issue":"6","key":"2022022809302389200_sct312661-bib-0008","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1172\/JCI70313","article-title":"Epigenetic reprogramming induces the expansion of cord blood stem cells","volume":"124","author":"Chaurasia","year":"2014","journal-title":"J Clin Invest"},{"key":"2022022809302389200_sct312661-bib-0009","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MOH.0000000000000143","article-title":"Role of epigenetic reprogramming in hematopoietic stem cell function","volume":"22","author":"Iancu-Rubin","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"2022022809302389200_sct312661-bib-0010","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1182\/blood.V128.22.818.818","article-title":"Preclinical development of a cord blood (CB)-derived hematopoietic stem cell (HSC) product for allogeneic transplantation in patients with hematological malignancies","volume":"128","author":"Iancu-Rubin","year":"2016","journal-title":"Blood"},{"key":"2022022809302389200_sct312661-bib-0011","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.stem.2007.10.001","article-title":"Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood","volume":"1","author":"Majeti","year":"2007","journal-title":"Cell Stem Cell"},{"key":"2022022809302389200_sct312661-bib-0012","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1201219","article-title":"Isolation of single human hematopoietic stem cells capable of long-term multiliniage engraftment","volume":"333","author":"Notta","year":"2011","journal-title":"Science"},{"issue":"6","key":"2022022809302389200_sct312661-bib-0013","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood-2004-02-0448","article-title":"Functional characterization of highly purified human hematopoietic human repopulating cells isolated according to aldehyde dehydrogenase activity","volume":"104","author":"Hess","year":"2004","journal-title":"Blood"},{"issue":"9","key":"2022022809302389200_sct312661-bib-0014","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bmt.1704928","article-title":"Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants","volume":"35","author":"Lioznov","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2022022809302389200_sct312661-bib-0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.tcb.2014.04.001","article-title":"Surviving change: the metabolic journey of hematopoietic stem cells","volume":"24","author":"Kohli","year":"2014","journal-title":"Trends Cell Biol"},{"key":"2022022809302389200_sct312661-bib-0016","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13125","article-title":"Specification of haematopoieitc stem cell fate via modulation of mitochondrial activity","volume":"7","author":"Vannini","year":"2016","journal-title":"Nat Commun"},{"issue":"7","key":"2022022809302389200_sct312661-bib-0017","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3324\/haematol.2012.079244","article-title":"Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function","volume":"98","author":"Romero-Moya","year":"2013","journal-title":"Haematologica"},{"issue":"3","key":"2022022809302389200_sct312661-bib-0018","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","article-title":"The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche","volume":"7","author":"Simsek","year":"2010","journal-title":"Cell Stem Cell"},{"key":"2022022809302389200_sct312661-bib-0019","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4067162","article-title":"Mitochondrial role in stemness and differentiation of hematopoietic stem cells","author":"Papa","year":"2019","journal-title":"Stem Cells Int"},{"key":"2022022809302389200_sct312661-bib-0020","article-title":"Ex vivo HSC expansion challenges the paradigm of unidirectional human hematopoiesis","author":"Papa","year":"2019","journal-title":"Ann N Y Acad Sci"},{"issue":"20","key":"2022022809302389200_sct312661-bib-0021","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1182\/bloodadvances.2018024273","article-title":"Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation","volume":"2","author":"Papa","year":"2018","journal-title":"Blood Adv"},{"issue":"11","key":"2022022809302389200_sct312661-bib-0022","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1182\/blood-2003-07-2431","article-title":"Modification of hematopoietic stem cell fate by 5aza2\u2019deoxycytidine and trichostatin A","volume":"103","author":"Milhem","year":"2014","journal-title":"Blood"},{"key":"2022022809302389200_sct312661-bib-0023","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/trf.12904","article-title":"Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers","volume":"55","author":"Saraf","year":"2015","journal-title":"Transfusion"},{"key":"2022022809302389200_sct312661-bib-0024","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1191536","article-title":"Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells","volume":"329","author":"Boitano","year":"2010","journal-title":"Science"},{"key":"2022022809302389200_sct312661-bib-0025","first-page":"3341","article-title":"Aryl hydrocarbon receptor antagonists expand adult hematopoietic stem cells from mobilized peripheral blood and bone marrow and increase the dose of CRISPR\/Cas9 gene-edited NSG-repopulating cells","volume":"130","author":"Hoban","year":"2017","journal-title":"Blood"},{"issue":"4","key":"2022022809302389200_sct312661-bib-0026","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/hgtb.2014.043","article-title":"Engraftment and lineage potential of adult hematopoietic stem and progenitor cells is compromised following short-term culture in the presencce of an aryl hydrocarbon receptor antagonist","volume":"25","author":"Gu","year":"2014","journal-title":"Hum Gene Ther Methods"},{"issue":"2","key":"2022022809302389200_sct312661-bib-0027","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jcyt.2012.10.014","article-title":"T-cell potential of human adult and cord blood hemopoietic stem cells expanded with the use of aryl hydrocarbon receptor antagonists","volume":"15","author":"Carlin","year":"2013","journal-title":"Cytotherapy"},{"issue":"10","key":"2022022809302389200_sct312661-bib-0028","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/sctm.17-0048","article-title":"Brief report: a differential transcriptomic profile of ex vivo expanded adult human hematopoietic stem cells empowers them for engraftment better than their surface phenotype","volume":"6","author":"Psatha","year":"2017","journal-title":"Stem Cell Trans"},{"issue":"8","key":"2022022809302389200_sct312661-bib-0029","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1182\/blood-2006-07-035287","article-title":"Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential","volume":"109","author":"Araki","year":"2007","journal-title":"Blood"},{"key":"2022022809302389200_sct312661-bib-0030","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.exphem.2009.05.012","article-title":"Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues","volume":"37","author":"Araki","year":"2009","journal-title":"Exp Hematol"},{"issue":"4","key":"2022022809302389200_sct312661-bib-0031","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1158\/0008-5472.CAN-04-3063","article-title":"Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells","volume":"65","author":"De Felice","year":"2005","journal-title":"Cancer Res"},{"issue":"6","key":"2022022809302389200_sct312661-bib-0032","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/scd.2008.0235","article-title":"Valproic acid increases CXCR4 expression in hematopoietic stem\/progenitor cells by chromatin remodeling","volume":"18","author":"Gul","year":"2009","journal-title":"Stem Cells Dev"},{"key":"2022022809302389200_sct312661-bib-0033","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbmt.2013.12.562","article-title":"Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem\/progenitor cells","volume":"20","author":"Mahmud","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2022022809302389200_sct312661-bib-0034","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1089\/scd.2011.0698","article-title":"Histone deacetylase 3 modulates the expansion of human hematopoietic stem cells","volume":"21","author":"Elizade","year":"2012","journal-title":"Stem Cells Dev"},{"issue":"1","key":"2022022809302389200_sct312661-bib-0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12360-0","article-title":"Zebrafish in-vivo screening for compounds amplifying hematopoietic stem and progenitor cells: preclinical validation in human CD34+ stem and progenitor cells","volume":"7","author":"Arulmozhivarman","year":"2017","journal-title":"Sci Rep"},{"issue":"414","key":"2022022809302389200_sct312661-bib-0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aan1145","article-title":"A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates","volume":"9","author":"Radtke","year":"2017","journal-title":"Sci Trans Med"},{"key":"2022022809302389200_sct312661-bib-0037","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0301-472X(01)00750-0","article-title":"Dissociation between stem cell phenotype and NOD\/SCID repopulating activity in human peripheral blood CD34+ cells after ex vivo expansion","volume":"29","author":"Danet","year":"2001","journal-title":"Exp Hematol"},{"issue":"8","key":"2022022809302389200_sct312661-bib-0038","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/hum.2019.009","article-title":"Constraints on human CD34+ cell fate due to lentiviral vectors can be relieved by valproic acid","volume":"30","author":"Moussy","year":"2019","journal-title":"Hum Gene Ther"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/sctm.19-0199","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/sctm.19-0199","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/9\/4\/531\/42627575\/stcltm_9_4_531.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/9\/4\/531\/42627575\/stcltm_9_4_531.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T04:36:25Z","timestamp":1646022985000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/9\/4\/531\/6406782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,1,17]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/sctm.19-0199","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737228337.793570094","asserted-by":"object"}]},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4,1]]},"published":{"date-parts":[[2020,1,17]]},"assertion":[{"value":"2019-07-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}